About Imax Diagnostic
Imax Diagnostic is a company based in Ringaskiddy (Ireland) founded in 2011 was acquired by Hovione in March 2018. Imax Diagnostic offers products and services including Contrast Agents, Active Pharmaceutical Ingredients, and Drug Products. Imax Diagnostic operates in a competitive market with competitors including Abzena, Patheon, Syngene, Piramal Group and LakePharma, among others.
- Headquarter Ringaskiddy, Ireland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Imax Diagnostic
Imax Diagnostic offers a comprehensive portfolio of products and services, including Contrast Agents, Active Pharmaceutical Ingredients, and Drug Products.
Generic agents for radiologic diagnostics like XRay and CT.
Raw materials for manufacturing generic drug products.
Finished generics for medical imaging applications.
Funding Insights of Imax Diagnostic
Detailed funding history for Imax Diagnostic
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Imax Diagnostic
Imax Diagnostic has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Hovione and Zhejiang Starry Pharmaceutical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO offering services for the development of innovator and generic drug substances and drug products
|
Locked | Locked | Locked | |
|
APIs and intermediates for contrast media and Fluoroquinolones are manufactured.
|
Locked | Locked | Locked |
Investor details for Imax Diagnostic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Imax Diagnostic
Investment portfolio details for Imax Diagnostic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imax Diagnostic
Detailed financials for Imax Diagnostic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imax Diagnostic Comparisons
Peer comparison for Imax Diagnostic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imax Diagnostic
Imax Diagnostic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Piramal Group and LakePharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| Locked | Locked | Locked |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
|
| Locked | Locked | Locked |
Provides enabling tools and services in the life sciences research and bio-production industries
|
Detailed competitors of Imax Diagnostic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imax Diagnostic
Complete news archive for Imax Diagnostic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imax Diagnostic
Imax Diagnostic was founded in 2011.
Imax Diagnostic is headquartered in Ringaskiddy, Ireland. It is registered at Ringaskiddy, County Cork, Ireland.
Imax Diagnostic was established in 2011 in Ringaskiddy, Ireland. Operations focus on the diagnostics sector, where active pharmaceutical ingredients are produced through manufacturing processes. Imaging services are also offered to support medical and research applications. The company maintains its primary base in Ireland, serving clients in pharmaceutical and healthcare fields with these specialized capabilities.
Imax Diagnostic's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
Imax Diagnostic offers Contrast Agents, Active Pharmaceutical Ingredients, and Drug Products.
Imax Diagnostic has 2 investors. Key investors include Hovione, and Zhejiang Starry Pharmaceutical.